Patient Reported Outcomes Articles & Publications

In December, 2009 the FDA issued its finalized Guidance on Patient Reported Outcomes (PRO) measures, capturing the FDA’s current thinking on PRO data capture in clinical research. The final Guidance is intended to help sponsors understand what the agency will look for when reviewing NDAs that include the collection of PRO data, including suggestions on how sponsors can best support claims in product labeling with study results measured by PRO instruments.

The scientists at PRO Consulting have published more than 100 peer-reviewed articles on PRO methods, and presented more than 500 papers at national and international conferences. Click here for a complete listing of our peer-reviewed publications on PRO data collection.

A sample of some of our recent papers on methodological issues affecting PRO data capture are listed below. Click on the title of any article in order to view a summary. To receive a copy of the article, please complete the form on the subsequent pages: